BIO Should Raise "Competing Moral Issues" In Cloning Debate - Feldbaum
Executive Summary
The Biotechnology Industry Organization needs to raise "competing moral issues" in response to religious objections to cloning, President Carl Feldbaum told the association's annual meeting June 25 in San Diego.
You may also be interested in...
BIO Preparing For Human Subject Protection Provisions In FDA Bills
The Biotechnology Industry Organization is preparing for the inclusion of human subject protection provisions in FDA bills scheduled for action in 2002.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials